SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Centaurus Financial Inc.

Centaurus Financial Inc. cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Rating) by 83.2% during the third quarter, HoldingsChannel reports. The firm owned 4,084 shares of the exchange traded fund’s stock after selling 20,198 shares during the period. Centaurus Financial Inc.’s holdings in SPDR S&P Biotech ETF were worth $324,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. RFG Advisory LLC increased its position in SPDR S&P Biotech ETF by 4.8% during the 2nd quarter. RFG Advisory LLC now owns 2,689 shares of the exchange traded fund’s stock worth $248,000 after purchasing an additional 123 shares during the period. PFG Advisors lifted its holdings in shares of SPDR S&P Biotech ETF by 2.1% during the third quarter. PFG Advisors now owns 6,465 shares of the exchange traded fund’s stock valued at $513,000 after purchasing an additional 130 shares during the last quarter. Firethorn Wealth Partners LLC boosted its position in shares of SPDR S&P Biotech ETF by 3.9% in the 3rd quarter. Firethorn Wealth Partners LLC now owns 3,615 shares of the exchange traded fund’s stock valued at $287,000 after purchasing an additional 135 shares during the period. United Capital Financial Advisers LLC increased its stake in SPDR S&P Biotech ETF by 0.9% in the 2nd quarter. United Capital Financial Advisers LLC now owns 16,527 shares of the exchange traded fund’s stock worth $1,227,000 after purchasing an additional 144 shares in the last quarter. Finally, Ancora Advisors LLC raised its holdings in SPDR S&P Biotech ETF by 47.9% during the 1st quarter. Ancora Advisors LLC now owns 491 shares of the exchange traded fund’s stock worth $67,000 after buying an additional 159 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $76.50 on Friday. The company has a 50-day moving average of $84.76 and a two-hundred day moving average of $82.58. The stock has a market cap of $7.19 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a one year low of $61.78 and a one year high of $97.19.

SPDR S&P Biotech ETF Profile

(Get Rating)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.